Search Results - "Cha, B.S"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation by Nam, J.S, Nam, J.Y, Yoo, J.S, Cho, M, Park, J.S, Ahn, C.W, Cha, B.S, Lee, E.J, Lim, S.K, Kim, K.R, Lee, H.C

    Published in Diabetes research and clinical practice (01-03-2010)
    “…Abstract Aims We investigated the effect of mosapride, 5HT-4 (5-hydroxytryptamine) agonist, on blood glucose level and insulin sensitivity in subjects with…”
    Get full text
    Journal Article
  9. 9

    Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women by Kim, D.M., Yoon, S.J., Ahn, C.W., Cha, B.S., Lim, S.K., Kim, K.R., Lee, H.C., Huh, K.B.

    Published in Diabetes research and clinical practice (01-12-2004)
    “…The aim of this study was to evaluate the effects of sibutramine on body composition and fat distribution, insulin resistance, and serum adiponectin levels in…”
    Get full text
    Journal Article
  10. 10

    Visceral fat amount is associated with carotid atherosclerosis even in type 2 diabetic men with a normal waist circumference by Kim, S K, Park, S W, Kim, S H, Cha, B S, Lee, H C, Cho, Y W

    Published in International Journal of Obesity (01-01-2009)
    “…Objective: Our objective was to investigate whether determination of the quantity of visceral fat has an additional benefit in assessing atherosclerotic burden…”
    Get full text
    Journal Article
  11. 11

    A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion by Kim, I, Kang, E S, Yim, Y S, Ko, S J, Jeong, S-H, Rim, J H, Kim, Y S, Ahn, C W, Cha, B S, Lee, H C, Kim, C H

    Published in The pharmacogenomics journal (01-06-2011)
    “…SLC30A8 encodes the β-cell-specific zinc transporter-8 (ZnT-8) expressed in insulin secretory granules. The single-nucleotide polymorphism rs13266634 of…”
    Get full text
    Journal Article
  12. 12

    multicenter, randomized, placebo‐controlled, double‐blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15‐0444 in patients with type 2 diabetes by Rhee, E.J, Lee, W.Y, Yoon, K.H, Yoo, S.J, Lee, I.K, Baik, S.H, Kim, Y.K, Lee, M.K, Park, K.S, Park, J.Y, Cha, B.S, Lee, H.W, Min, K.W, Bae, H.Y, Kim, M.J, Kim, J.A, Kim, D.K, Kim, S.W

    Published in Diabetes, obesity & metabolism (01-12-2010)
    “…Aim: The objective of this study was to evaluate the optimal dose, efficacy and safety of a novel dipeptidyl peptidase‐4 (DPP‐IV) inhibitor, LC15‐0444, in…”
    Get full text
    Journal Article
  13. 13
  14. 14

    An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea by Kim, D.M., Ahn, C.W., Park, J.S., Cha, B.S., Lim, S.K., Kim, K.R., Lee, H.C., Huh, K.B.

    Published in Diabetes research and clinical practice (01-12-2004)
    “…This study was undertaken to investigate diverse risk factors affecting the progression of diabetic nephropathy (DN) by observing the changes of 24h urinary…”
    Get full text
    Journal Article